Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01930799 · ClinicalTrials.gov registry record · Phase 4
Bladder Management in Patients With Multiple Sclerosis: Optimizing Practice Patterns
A Phase 4 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
NCT01930799 is a Phase 4 study that has completed, run by Allergan. The registered enrollment target is 120 participants.
The verdict
NCT01930799, a Phase 4 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
Study Summary
This study will assess the impact of a systematic bladder health screening and disease education regimen as well as the implementation of a referral process on the quality of life of multiple sclerosis patients with bladder dysfunction.
Interventions
- BEHAVIORAL Systematic Screening and Education Regimen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2013-08 |
| Est. Completion | 2015-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01930799
The ClinicalTrials.gov registry entry for NCT01930799 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Systematic Screening and Education Regimen is the first listed.
NCT01930799 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01930799 about?
NCT01930799 is a clinical study titled "Bladder Management in Patients With Multiple Sclerosis: Optimizing Practice Patterns". This study will assess the impact of a systematic bladder health screening and disease education regimen as well as the implementation of a referral process on the quality of life of multiple sclerosis patients with bladder dysfunction.
What is the current status of trial NCT01930799?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2013-08. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01930799?
The interventions under investigation include: Systematic Screening and Education Regimen (BEHAVIORAL).
Who is sponsoring clinical trial NCT01930799?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.